| Schedule of Calculation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders |
The following table presents the calculation of basic and diluted net income (loss) per share attributable to common stockholders for the three and six months ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | 2026 | | 2025 | | 2026 | | 2025 | | Numerator: | | | | | | | | | Net income (loss) | $ | (42,817) | | | $ | (74,724) | | | $ | (67,845) | | | $ | 55,208 | | | Earnings attributable to participating Class A Common Shares held in escrow in connection with Amelia acquisition | — | | | — | | | — | | | (297) | | | | | | | | | | | Net income (loss) attributable to common shareholders - basic | $ | (42,817) | | | $ | (74,724) | | | $ | (67,845) | | | $ | 54,911 | | | | | | | | | | | Net income (loss) | (42,817) | | | (74,724) | | | (67,845) | | | 55,208 | | | Effect of potentially dilutive equivalent shares to net income (loss) | (2,365) | | | (602) | | | (24,869) | | | (1,503) | | | | | | | | | | | Net income (loss) attributable to common shareholders - diluted | $ | (45,182) | | | $ | (75,326) | | | $ | (92,714) | | | $ | 53,705 | | | | | | | | | | | Denominator: | | | | | | | | | Weighted average shares outstanding – basic | 430,521,776 | | 400,124,499 | | 426,022,299 | | 397,026,119 | | Effect of potentially dilutive equivalent shares | 8,126,674 | | 1,918,969 | | | 8,218,016 | | 17,119,758 | | | Weighted average shares outstanding – diluted | 438,648,450 | | 402,043,468 | | 434,240,315 | | 414,145,877 | | | | | | | | | | Basic net income (loss) per share | $ | (0.10) | | | $ | (0.19) | | | $ | (0.16) | | | $ | 0.14 | | | Diluted net income (loss) per share | $ | (0.10) | | | $ | (0.19) | | | $ | (0.21) | | | $ | 0.13 | |
|
| Schedule of Outstanding Shares of Potentially Dilutive Securities |
The following table summarizes the outstanding shares of potentially dilutive securities that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive for the three and six months ended June 30, 2026 and 2025: | | | | | | | | | | | | | As of June 30, | | 2026 | | 2025 | | Stock-based awards | 11,514,340 | | 12,477,419 | | Unvested restricted stock awards | 42,940 | | 280,953 | | Contingently issuable shares | 1,545,138 | | 10,385 | | Total | 13,102,418 | | 12,768,757 |
|